| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $0.01427 (Beat by $0.0107) |
| EPS GAAP Actual | $0.01427 (Beat by $0.0107) |
| Revenue Actual | $0.14969B |
| Revenue Surprise | Beat by $149.69M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.00222645 |
| EPS GAAP Estimate | $0.00222645 |
| Revenue Estimate | $0.156789633B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Oct 2030 | 0.86463 | 2.8 | 0.81296 | 0.92886 | 1 |
| Oct 2029 | 0.75254 | 3.22 | 0.74184 | 0.76562 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0.0074 | 0.0074 | 0.14969B | 12.03% | 23.38M |
| FQ2 2025 (Apr 2025) | -0.04 | -0.04 | 0.137804B | 9.83% | 16.89M |
| FQ1 2025 (Jan 2025) | -0.0353 | -0.0353 | 0.142461B | 10.1% | 6.45M |
| FQ4 2024 (Oct 2024) | -0.0044 | -1.54581 | 0.138295B | 8.09% | -157.05M |
| FQ3 2024 (Jul 2024) | 0.01 | 0.01 | 0.131685B | 5.57% | 131.69M |
| FQ3 2017 (Jul 2017) | 0.68 | 0.68 | 0.00292463B | 100% | 2.92M |
| FQ4 2017 (Oct 2017) | -0.28 | -0.28 | 0.00267451B | 100% | 2.67M |
| FQ2 2024 (Apr 2024) | -0.0003 | -0.0003 | 0.124259B | 4.93% | 124.26M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
0.00222645
Consensus Revenue Estimates
0.156789633B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Apr 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Jan 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Oct 2026) | 0.01629355 | -- | 0.01626453 | 0.01633707 | 1 |
| FQ3 2026 (Jul 2026) | 0.01406711 | 47.4 | 0.01404206 | 0.01410469 | 1 |
| FQ2 2026 (Apr 2026) | -0.01038568 | -285.15 | -0.01045392 | -0.01032719 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Jul 2027) | 0.21B | -- | 0.2B | 0.22B | 1 |
| FQ2 2027 (Apr 2027) | 0.2B | -- | 0.2B | 0.21B | 1 |
| FQ1 2027 (Jan 2027) | 0.2B | -- | 0.2B | 0.21B | 1 |
| FQ4 2026 (Oct 2026) | 0.17B | -- | 0.17B | 0.17B | 2 |
| FQ3 2026 (Jul 2026) | 0.16B | 7.51 | 0.16B | 0.16B | 2 |
| FQ2 2026 (Apr 2026) | 0.16B | 16.08 | 0.16B | 0.17B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0 | 0.0074 | 0.0074 | 100% |
| FQ2 2025 (Apr 2025) | 0 | -0.04 | -0.04 | 100% |
| FQ1 2025 (Jan 2025) | 0 | -0.0353 | -0.0353 | 100% |
| FQ4 2024 (Oct 2024) | 1.54141 | -0.0044 | -1.54581 | 35132.05% |
| FQ3 2024 (Jul 2024) | 0.01 | 0.01 | 100% | |
| FQ3 2017 (Jul 2017) | 0.68 | 0.68 | 100% | |
| FQ4 2017 (Oct 2017) | -0.28 | -0.28 | 100% | |
| FQ2 2024 (Apr 2024) | -0.0003 | -0.0003 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | $0.13B | $0.15B | $23.38M | 15.62% |
| FQ2 2025 (Apr 2025) | $0.12B | $0.14B | $16.89M | 12.26% |
| FQ1 2025 (Jan 2025) | $0.14B | $0.14B | $6.45M | 4.53% |
| FQ4 2024 (Oct 2024) | $0.3B | $0.14B | $-157.05M | -113.56% |
| FQ3 2024 (Jul 2024) | $0B | $0.13B | $131.69M | 100% |
| FQ3 2017 (Jul 2017) | $0B | $0B | $2.92M | 100% |
| FQ4 2017 (Oct 2017) | $0B | $0B | $2.67M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.12B | $124.26M | 100% |